Michaël Facompré
Impact in
- Organic Chemistry top 5%
- Synthesis and biological activity
- Advanced Synthetic Organic Chemistry
- Synthesis and Characterization of Pyrroles
-
- Synthesis and Biological Activity
Papers in
-
- Cancer therapeutics and mechanisms 15
- DNA and Nucleic Acid Chemistry 5
- Cell death mechanisms and regulation 1
- RNA Research and Splicing 1
-
- Synthesis and pharmacology of benzodiazepine derivatives 4
- Synthesis and biological activity 2
- Co-authors
- Christian Bailly (17 shared papers)Pierre Colson (7 shared papers)Christelle Tardy (3 shared papers)Ignacio Manzanares (2 shared papers)Carmen Cuevas (2 shared papers)Jean‐François Goossens (6 shared papers)Christine Mahieu (1 shared paper)Amélie Lansiaux (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (3 papers)ChemBioChem (2 papers)Bioorganic & Medicinal Chemistry (2 papers)European Journal of Medicinal Chemistry (2 papers)Molecular Pharmacology (2 papers)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Michaël Facompré
18 papers receiving 729 citations
Peers
Comparison fields: 5 of 55
- Organic Chemistry 305
- Cancer Research 83
- Molecular Biology 349
- Biotechnology 37
- Drug Discovery 1
Countries citing papers authored by Michaël Facompré
This map shows the geographic impact of Michaël Facompré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Facompré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Facompré more than expected).
Fields of papers citing papers by Michaël Facompré
This network shows the impact of papers produced by Michaël Facompré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Facompré. The network helps show where Michaël Facompré may publish in the future.
Co-authors
The 25 scholars most cited alongside Michaël Facompré, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lamellarin D: a novel potent inhibitor of topoisomerase I. | 2003 | 180 |
| 2 | Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. | 2001 | 114 |
| 3 | 2004 | 97 | |
| 4 | 2002 | 60 | |
| 5 | 2000 | 49 | |
| 6 | 2000 | 46 | |
| 7 | 2004 | 39 | |
| 8 | 2002 | 30 | |
| 9 | 2001 | 27 | |
| 10 | 2001 | 21 | |
| 11 | 2002 | 21 | |
| 12 | 2001 | 18 | |
| 13 | 2002 | 16 | |
| 14 | 2001 | 12 | |
| 15 | 2003 | 10 | |
| 16 | 2002 | 8 | |
| 17 | 2003 | 5 | |
| 18 | 2003 | 1 |
About Michaël Facompré
Michaël Facompré is a scholar working on Molecular Biology, Organic Chemistry, Toxicology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 18 papers that have together received 754 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (15 papers), DNA and Nucleic Acid Chemistry (5 papers), Synthesis and pharmacology of benzodiazepine derivatives (4 papers), Synthesis and biological activity (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Cell death mechanisms and regulation (1 paper) and RNA Research and Splicing (1 paper). The work is most often cited by research in Organic Chemistry (305 citations), Cancer Research (83 citations), Molecular Biology (349 citations), Biotechnology (37 citations) and Drug Discovery (1 citation). Michaël Facompré has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Christian Bailly, Pierre Colson, Christelle Tardy, Ignacio Manzanares, Carmen Cuevas, Jean‐François Goossens, Christine Mahieu, Amélie Lansiaux, Jean‐Pierre Hénichart and Jamal Tazi. Their work appears in journals such as Journal of Medicinal Chemistry, ChemBioChem, Bioorganic & Medicinal Chemistry, European Journal of Medicinal Chemistry and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.